| Clinical data | |
|---|---|
| Other names | 4-Methylseleno-2,5-dimethoxyphenethylamine; |
| Routes of administration | Oral |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Pharmacokinetic data | |
| Onset of action | 45 minutes |
| Duration of action | 6–8 hours |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C11H17NO2Se |
| Molar mass | 274.233 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 240 to 241 °C (464 to 466 °F) |
| |
| |
2C-Se, also known as 4-methylseleno-2,5-dimethoxyphenethylamine, is a psychedelic drug of the phenethylamine and 2C families.
It was originally named by Alexander Shulgin as described in his book PiHKAL (Phenethylamines I Have Known and Loved). Shulgin listed its dose as perhaps 100 mg orally and its duration as 6 to 8 hours. Its onset was 45 minutes, peak effects occurred after 1.5 hours, and doses of 50 to 70 mg orally produced threshold effects. Shulgin considered 2C-Se to be around three times the potency of mescaline, but was too concerned about toxicity to test it extensively, though he considered it noteworthy as the only psychedelic drug to contain a selenium atom.
The chemical synthesis of 2C-Se has been described.
2C-Se was first described in the literature by Shulgin in PiHKAL in 1991. It is a controlled substance in Canada under phenethylamine blanket-ban language.
| Phenethylamines |
| ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amphetamines |
| ||||||||||||||||
| Phentermines |
| ||||||||||||||||
| Cathinones |
| ||||||||||||||||
| Phenylisobutylamines (and further-extended) |
| ||||||||||||||||
| Catecholamines (and close relatives) |
| ||||||||||||||||
| Cyclized phenethylamines |
| ||||||||||||||||
| Related compounds |
| ||||||||||||||||